CDMO - November 4, 2019
Recipharm launches a stand-alone offering for analytical chemistry
The company has launched Recipharm Analytical Solutions, a stand-alone service to support pharmaceutical companies with their Quality Control (QC) and analytical requirements. Recipharm Analytical Solutions, which launches at CPhI Worldwide, November 5 – 7, Frankfurt, Germany, offers analytical services including method development, method validation, and stability program design and implementation, states the company in its […]
In a new job - February 13, 2019
Recipharm appoints new Director of Business Management
Recipharm has appointed Kieran Chouhan as new director of business management for the USA and Canada. With over eight years of experience working in the North American CDMO industry, he joins the business management team at Recipharm to lead sales activity in North America. In his new role, Kieran will be responsible for sales and business […]
CDMO - November 13, 2017
Recipharm to end operations in two facilities in Sweden
Recipharm has announced that it will initiate a process with the intention of discontinuing manufacturing operations at its facilities in Stockholm and Höganäs, Sweden. Since 2015, Recipharm has been implementing efficiency activities in the Swedish part of the business segment known as Solids and Others. These initiatives have included a reduction in headcount and the […]
CDMO - October 24, 2017
Recipharm equips Lisbon facility for US and European serialisation
Recipharm has equipped its sixth facility with serialisation capabilities before the US and European regulation enforcement deadlines. The facility in Lisbon is the latest of Recipharm’s facilities to be prepared to start supplying serialised products to the US and Europe, following a EUR 40 million investment into its company-wide implementation programme in 2016. The Lisbon […]
CDMO - August 9, 2017
Recipharm and LIDDS establish industrial manufacturing capabilities
Recipharm and LIDDS have together set up a manufacturing line for LIDDS’ novel prostate cancer drug, LiprocaDepot, at Recipharm in Solna. The manufacturing line is dedicated to the first product based on LIDDS’ NanoZolidtechnology. Clinical trial material has already been produced and the facility is ready for future commercial manufacturing of Liproca Depot or other […]
In a new job - April 22, 2017
Henrik Stenqvist is Recipharm’s new CFO
Recipharm announces the appointment of Henrik Stenqvist as its new Executive Vice President and Chief Financial Officer, effective on April 24, 2017. Henrik Stenqvist will be based at the company’s headquarters in Stockholm and reports to Thomas Eldered, Chief Executive Officer of Recipharm. Stenqvist brings 24 years’ finance and management experience to Recipharm. Prior to […]
